Skip to content

Cytokinetics

US · CYTK #1564 by market cap Listed 1970
50.78 -0.68 -1.32%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
D+
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 1 upgrade vs 0 downgrades among tracked analyst rating changes.
  • Most recent: UBS moved from Hold to Buy on 2026-06-29.

Analyst consensus 16 analysts

Buy
Avg price target 107.29 +111.3%
Price target rangecurrent 50.78
Low78.00
Avg107.29
High140.00
Buy 94% Hold 6% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-09 H.C. Wainwright -- Buy 140.00
2026-11-06 Truist Financial -- Buy 112.00
2026-11-06 Citi -- Buy 105.00
2026-11-05 Wells Fargo -- Buy 105.00
2026-11-05 Piper Sandler -- Buy 107.00
2026-11-05 Morgan Stanley -- Buy 103.00
2026-11-05 Evercore -- Buy 100.00
2026-11-05 Stifel -- Buy 108.00
2026-11-05 Citi -- Buy 105.00
2026-11-05 H.C. Wainwright -- Buy 140.00
2026-11-05 Barclays -- Buy 110.00
2026-11-04 BofA Securities -- Hold 78.00
2026-11-04 RBC Capital -- Buy 113.00
2026-11-03 Morgan Stanley -- Buy 103.00
2026-10-19 BofA Securities -- Hold 81.00
2026-10-19 H.C. Wainwright -- Buy 140.00
2026-10-15 William Blair -- Buy --
2026-10-15 UBS -- Buy 104.00
2026-10-14 UBS -- Buy 104.00
2026-10-14 RBC Capital -- Buy 113.00
2026-10-14 J.P. Morgan -- Buy --
2026-10-13 H.C. Wainwright -- Buy 140.00
2026-10-08 RBC Capital -- Buy 113.00
2026-10-05 Needham -- Buy 112.00
2026-10-05 H.C. Wainwright -- Buy 140.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-06-29 UBS Hold → Buy 115.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-04 After close ±8.89% -12.66% (beat)
2026/Q2 2026-08-06 After close ±7.47% -5.67% (in line)
2026/Q1 2026-05-05 After close ±9.52% -2.92% (in line)
2025/Q4 2026-02-24 After close ±9.08% -10.29% (beat)
2025/Q3 2025-11-05 After close ±7.87% +1.88% (in line)
2025/Q2 2025-08-07 After close ±11.80% -3.23% (in line)
2025/Q1 2025-05-06 After close ±15.94% -2.74% (in line)
2024/Q4 2025-02-27 After close ±16.40% -3.06% (in line)
2024/Q3 2024-11-06 After close ±10.73% +0.61% (in line)
2024/Q2 2024-08-08 After close ±14.46% +3.31% (in line)
2024/Q1 2024-05-08 After close ±6.51% -1.92% (in line)
2023/Q4 2024-02-27 After close ±7.96% -9.75% (beat)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:43 · For reference only, not investment advice and not tailored to your situation.

Cytokinetics discussion 0 comments

Add a comment